Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial

BACKGROUND: Group A streptococcus (GAS) is a serious human pathogen that affects people of different ages and socio-economic levels. Although vaccination is potentially one of the most effective methods to control GAS infection and its sequelae, few prototype vaccines have been investigated in human...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekuloski, Silvana, Batzloff, Michael R., Griffin, Paul, Parsonage, William, Elliott, Suzanne, Hartas, Jon, O’Rourke, Peter, Marquart, Louise, Pandey, Manisha, Rubin, Fran A., Carapetis, Jonathan, McCarthy, James, Good, Michael F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028081/
https://www.ncbi.nlm.nih.gov/pubmed/29965967
http://dx.doi.org/10.1371/journal.pone.0198658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028081/
https://www.ncbi.nlm.nih.gov/pubmed/29965967
http://dx.doi.org/10.1371/journal.pone.0198658

Ejemplares similares